Skip to main content

Advertisement

SpringerLink
Log in

L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension

The US experience

  • ARTICLE
  • Published:
Clinical Autonomic Research Aims and scope Submit manuscript

Abstract

Neurogenic orthostatic hypotension results from failure to release norepinephrine, the neurotransmitter of sympathetic postganglionic neurons, appropriately upon standing. In double blind, cross over, placebo controlled trials, administration of droxidopa, a synthetic amino acid that is decarboxylated to norepinephrine by the enzyme l-aromatic amino acid decarboxylase increases standing blood pressure, ameliorates symptoms of orthostatic hypotension and improves standing ability in patients with neurogenic orthostatic hypotension due to degenerative autonomic disorders. The pressor effect results from conversion of droxidopa to norepinephrine outside the central nervous system both in neural and non-neural tissue. This mechanism of action makes droxidopa effective in patients with central and peripheral autonomic disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Bartholini J, Constantinidis J, Puig M, Tissot R, Pletscher A (1975) The stereoisomers of 3,4-dihydroxyphenylserine as precursors of norepinephrine. J Pharmacol Exp Ther 193:523–532

    PubMed  CAS  Google Scholar 

  2. Biaggioni I, Robertson D (1987) Endogenous restoration of noradrenaline by precursor therapy in dopamine-beta-hydroxylase deficiency. Lancet 2:1170–1172

    Article  PubMed  CAS  Google Scholar 

  3. Blaschko H, Burn JH, Langemann H (1950) The formation of noradrenaline from dihydroxyphenylserine. Br J Pharmacol 5:431–437

    CAS  Google Scholar 

  4. Freeman R, Landsberg L, Young J (1999) The treatment of neurogenic orthostatic hypotension with 3,4-dl-threo-dihydroxyphenylserine: a randomized, placebo-controlled, crossover trial. Neurology 53:2151–2157

    PubMed  CAS  Google Scholar 

  5. Gibbons CH, Vernino SA, Kaufmann H, Freeman R (2005) l-DOPS therapy for refractory orthostatic hypotension in autoimmune autonomic neuropathy. Neurology 65:1104–1106

    Article  PubMed  Google Scholar 

  6. Goldstein DS, Holmes C, Kaufmann H, Freeman R (2004) Clinical pharmacokinetics of the norepinephrine precursor l-threo-DOPS in primary chronic autonomic failure. Clin Auton Res 14:363–368

    Article  PubMed  Google Scholar 

  7. Hague K, Lento P, Morgello S, Caro S, Kaufmann H (1997) The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature. Acta Neuropathol (Berl) 94:192–196

    Article  CAS  Google Scholar 

  8. Inagaki C, Fujiwara H, Tanaka C (1976) Inhibitory effect of (+)threo-3,4-dihydroxy-phenylserine (DOPS) on decarboxylation of (−)threo-dops. Jpn J Pharmacol 26:380–382 Issn: 0021-5198

    Article  PubMed  CAS  Google Scholar 

  9. Kaufmann H (1996) Could treatment with DOPS do for autonomic failure what DOPA did for Parkinson’s disease? Neurology 47:1370–1371

    PubMed  CAS  Google Scholar 

  10. Kaufmann H, Oribe E, Yahr MD (1991) Differential effect of l-threo-3,4-dihydroxyphenylserine in pure autonomic failure and multiple system atrophy with autonomic failure. J Neural Transm Park Dis Dement Sect 3:143–148

    Article  PubMed  CAS  Google Scholar 

  11. Kaufmann H, Saadia D, Voustianiouk A, Goldstein DS, Holmes C, Yahr MD, Nardin R, Freeman R (2003) Norepinephrine precursor therapy in neurogenic orthostatic hypotension. Circulation 108:724–728

    Article  PubMed  CAS  Google Scholar 

  12. Man in’t Veld AJ, Boomsma F, van den Meiracker AH, Schalekamp MA (1987) Effect of unnatural noradrenaline precurser on sympathetic control and orthostatic hypotension in dopamine-beta-hydroxylase defficiency. Lancet 2:1172–1175

    Google Scholar 

  13. Mathias CJ, Senard JM, Braune S, Watson L, Aragishi A, Keeling JE, Taylor MD (2001) l-threo-dihydroxyphenylserine (l-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure. Clin Auton Res 11:235–242

    Article  PubMed  CAS  Google Scholar 

  14. Polinsky RJ, Kopin IJ, Ebert MH, Weise V (1981) Pharmacologic distinction of different orthostatic hypotension syndromes. Neurology 31:1–7

    PubMed  CAS  Google Scholar 

  15. Schmiterlow CG (1951) The formation in vivo of noradrenaline from 3:4-dihydroxyphenylserine (noradrenaline carboxylic acid). Br J Pharmacol 6:127–134

    CAS  Google Scholar 

  16. Suzuki T, Higa S, Tsuge I, Sakoda S, Hayashi A, Yamamura Y, Takaba Y, Nakajima A (1980) Effect of infused l-threo-3,4-dihydroxyphenylserine on adrenergic activity in patients with familial amyloid polyneuropathy. Eur J Clin Pharmacol 17:429–435

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

I am grateful to Dr. Lucy Norcliffe-Kaufmann for her help designing the figures. Disclosure Dr. Kaufmann has served as a consultant for Chelsea Therapeutics.

Author information

Authors and Affiliations

  1. Dysautonomia Research Laboratory, New York University School of Medicine, 530 First Avenue, New York, NY, 10016, USA

    Horacio Kaufmann MD

Authors
  1. Horacio Kaufmann MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Horacio Kaufmann MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaufmann, H. L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension. Clin Auton Res 18 (Suppl 1), 19–24 (2008). https://doi.org/10.1007/s10286-007-1002-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10286-007-1002-2

Key words

Search

Navigation